<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
    	<title>IJPRS/V3/I2/00273 - 30/05/2014</title>

	<item>
		<title>Formulation and Evaluation of Niacin Extended Release Tablets</title>
		
		<description><![CDATA[<h5>Author's Affiliation</h5>
		                                                <p></p>
		                                                <hr/>
                                                    	<h5>Abstract</h5>
		                                                <p>Present study aims to prepare and evaluate niacin extended release tablets.  The Matrix tablets each containing 1000 mg of niacin are formulated employing ethyl cellulose (10cps &amp; 50cps)/ eudragits (FS-30D, NE-40D, RL-30D) in various proportions as rate controlling polymers. All the matrix tablets are prepared by wet granulation method and are evaluated for hardness, friability, average weight, and dissolution rate. A total of 10 formulations are prepared and estimated for comparison, dissolution rate of innovator product (Niaspan) is also studied, among all formulations F10 is found to be the best as all properties including dissolution rate are similar to those of innovators product.</p>
                                                    	<hr/>
                                                        <h5>Keywords</h5>
                                                         <p>Niacin, Extended release, Ethyl cellulose, Eudragits, Wet granulation</p>
                                                         
                                                    	                                                    	<hr/>
                                                         <h5>Cite This Article</h5>
                                                         <p>Kumar, Y. M., &amp; kumar, M. K. (2014). Formulation and Evaluation of Niacin Extended Release Tablets. <em>International Journal for Pharmaceutical Research Scholars (IJPRS), 3(2),</em> 602-608.</p>                                                         <hr/>
                                                         <p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fformulation-and-evaluation-of-niacin-extended-release-tablets%2F&amp;linkname=Formulation%20and%20Evaluation%20of%20Niacin%20Extended%20Release%20Tablets" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fformulation-and-evaluation-of-niacin-extended-release-tablets%2F&amp;linkname=Formulation%20and%20Evaluation%20of%20Niacin%20Extended%20Release%20Tablets" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fformulation-and-evaluation-of-niacin-extended-release-tablets%2F&#038;title=Formulation%20and%20Evaluation%20of%20Niacin%20Extended%20Release%20Tablets" data-a2a-url="https://www.ijprs.com/article/formulation-and-evaluation-of-niacin-extended-release-tablets/" data-a2a-title="Formulation and Evaluation of Niacin Extended Release Tablets"></a></p>]]>
        </description>
		<link>https://www.ijprs.com/article/formulation-and-evaluation-of-niacin-extended-release-tablets/</link>
		<author>Kumar, Y. M., kumar, M. K.        </author>

		<pdflink>http://www.ijprs.com/wp-content/uploads/2018/09/IJPRS-V3-I2-00273.pdf</pdflink>

	</item>
</channel>
</rss>
